148 related articles for article (PubMed ID: 33568899)
21. The role of trust in the acceptance of adjuvant endocrine therapy in breast cancer patients.
Constanze E; Uwe G; Christoph T; Kavitha D; Dominik R; Urte S; Walter B
Psychooncology; 2022 Dec; 31(12):2122-2131. PubMed ID: 36251608
[TBL] [Abstract][Full Text] [Related]
22. Religion and spirituality: their role in the psychosocial adjustment to breast cancer and subsequent symptom management of adjuvant endocrine therapy.
Toledo G; Ochoa CY; Farias AJ
Support Care Cancer; 2021 Jun; 29(6):3017-3024. PubMed ID: 33034750
[TBL] [Abstract][Full Text] [Related]
23. Silent suffering: the impact of sexual health challenges on patient-clinician communication and adherence to adjuvant endocrine therapy among Black women with early-stage breast cancer.
Anderson JN; Paladino AJ; Blue R; Dangerfield DT; Eggly S; Martin MY; Schwartzberg LS; Vidal GA; Graetz I
J Cancer Surviv; 2023 Dec; ():. PubMed ID: 38114711
[TBL] [Abstract][Full Text] [Related]
24. Adherence trajectories of adjuvant endocrine therapy in the five years after its initiation among women with non-metastatic breast cancer: a cohort study using administrative databases.
Lambert-Côté L; Bouhnik AD; Bendiane MK; Bérenger C; Mondor M; Huiart L; Lauzier S
Breast Cancer Res Treat; 2020 Apr; 180(3):777-790. PubMed ID: 32086655
[TBL] [Abstract][Full Text] [Related]
25. Development of a community pharmacy-based intervention to enhance adherence to adjuvant endocrine therapy among breast cancer survivors guided by the Intervention Mapping approach.
Labonté M; Guillaumie L; Dionne A; Dorval M; Nabi H; Lemieux J; Provencher L; Lauzier S
Res Social Adm Pharm; 2020 Dec; 16(12):1724-1736. PubMed ID: 32205070
[TBL] [Abstract][Full Text] [Related]
26. Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.
Lambert LK; Balneaves LG; Howard AF; Gotay CC
Breast Cancer Res Treat; 2018 Feb; 167(3):615-633. PubMed ID: 29110151
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer patients' experiences of adherence and persistence to oral endocrine therapy: A qualitative evidence synthesis.
Clancy C; Lynch J; OConnor P; Dowling M
Eur J Oncol Nurs; 2020 Feb; 44():101706. PubMed ID: 32007696
[TBL] [Abstract][Full Text] [Related]
28. The experiences of adjuvant endocrine therapy for women breast cancer survivors: A literature review.
Long Y; Xie S; Liu Q; Xu F; Li Q; Wang N; Zhang Y
Medicine (Baltimore); 2023 Dec; 102(51):e36704. PubMed ID: 38134074
[TBL] [Abstract][Full Text] [Related]
29. Associations between adjuvant endocrine therapy and onset of physical and emotional concerns among breast cancer survivors.
van Londen GJ; Beckjord EB; Dew MA; Cooper KL; Davidson NE; Bovbjerg DH; Donovan HS; Thurston RC; Morse JQ; Nutt S; Rechis R
Support Care Cancer; 2014 Apr; 22(4):937-45. PubMed ID: 24271937
[TBL] [Abstract][Full Text] [Related]
30. Identification of patient subgroups who benefit from a behavioral intervention to improve adjuvant endocrine therapy adherence: a randomized-controlled trial.
Walsh EA; Post K; Massad K; Horick N; Antoni MH; Penedo FJ; Safren SA; Partridge AH; Peppercorn J; Park ER; Temel JS; Greer JA; Jacobs JM
Breast Cancer Res Treat; 2024 Apr; 204(3):547-559. PubMed ID: 38231313
[TBL] [Abstract][Full Text] [Related]
31. Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management.
Cavazza M; Banks H; Ercolanoni M; Cukaj G; Bianchi G; Capri G; Longo F
Breast Cancer Res Treat; 2020 Aug; 183(1):189-199. PubMed ID: 32591986
[TBL] [Abstract][Full Text] [Related]
32. Beliefs and attitudes toward endocrine therapy in patients with hormone receptor-positive breast cancer.
Kim Y; Min YH; Lee SB
Health Care Women Int; 2021 Sep; 42(7-9):1086-1097. PubMed ID: 32886576
[TBL] [Abstract][Full Text] [Related]
33. It's not an easy fix: Adherence to adjuvant endocrine therapy after breast cancer.
Lambert LK; Balneaves LG; Howard AF
Can Oncol Nurs J; 2021; 31(2):221-227. PubMed ID: 34036161
[TBL] [Abstract][Full Text] [Related]
34. Concurrent factors associated with adherence to adjuvant endocrine therapy among women with non-metastatic breast cancer.
Walsh EA; Walsh LE; Hernand M; Horick N; Antoni MH; Temel JS; Greer JA; Jacobs JM
J Cancer Surviv; 2024 Feb; ():. PubMed ID: 38401012
[TBL] [Abstract][Full Text] [Related]
35. Facilitators and barriers to medication adherence with adjuvant endocrine therapy in women with breast cancer: a structural equation modelling approach.
Tan EH; Wong ALA; Tan CC; Wong P; Tan SH; Ang LEY; Lim SE; Chong WQ; Ho J; Lee SC; Tai BC
Breast Cancer Res Treat; 2021 Aug; 188(3):779-788. PubMed ID: 33948777
[TBL] [Abstract][Full Text] [Related]
36. A Survey of Potentially Modifiable Patient-Level Factors Associated with Self-Report and Objectively Measured Adherence to Adjuvant Endocrine Therapies After Breast Cancer.
Toivonen KI; Carlson LE; Rash JA; Campbell TS
Patient Prefer Adherence; 2021; 15():2039-2050. PubMed ID: 34552322
[TBL] [Abstract][Full Text] [Related]
37. Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens.
Tan X; Camacho TF; LeBaron VT; Blackhall LJ; Balkrishnan R
Breast Cancer Res Treat; 2017 Sep; 165(2):455-465. PubMed ID: 28639031
[TBL] [Abstract][Full Text] [Related]
38. Potentially Modifiable Factors Associated with Adherence to Adjuvant Endocrine Therapy among Breast Cancer Survivors: A Systematic Review.
Toivonen KI; Williamson TM; Carlson LE; Walker LM; Campbell TS
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33561076
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence.
Lee C; Check DK; Manace Brenman L; Kushi LH; Epstein MM; Neslund-Dudas C; Pawloski PA; Achacoso N; Laurent C; Fehrenbacher L; Habel LA
Breast Cancer Res Treat; 2020 Feb; 180(1):219-226. PubMed ID: 31975315
[TBL] [Abstract][Full Text] [Related]
40. Predicting adjuvant endocrine therapy initiation and adherence among older women with early-stage breast cancer.
Meneveau MO; Keim-Malpass J; Camacho TF; Anderson RT; Showalter SL
Breast Cancer Res Treat; 2020 Dec; 184(3):805-816. PubMed ID: 32920742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
